Le Xu - Publications

Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategies.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 20, 2026

Matrix stiffening-driven hepatocellular carcinoma progression through OASL-mediated cGAS-STING repression and subsequent macrophage activation.

Journal: International immunopharmacology

Published: October 11, 2025

PRMT5 inhibits the ferroptosis of hepatocellular carcinoma via regulating RBM15/FTH1 signaling.

Journal: American journal of cancer research

Published: May 04, 2025

CYP8B1 inhibits hepatocellular carcinoma progression by repressing PAK4 transcription through inhibition of nuclear translocation of u-STAT1.

Journal: Cell death & disease

Published: March 15, 2025

m6A-modified circCCAR1 promotes malignant proliferation by enhancing KIF5B expression in hepatocellular carcinoma.

Journal: Journal of physiology and biochemistry

Published: February 24, 2025

NSMCE2 promotes the occurrence and development of HCC by regulating the SUMOylation of PPARα.

Journal: International immunopharmacology

Published: February 15, 2025

IGFALS suppresses hepatocellular carcinoma progression by stabilizing PPAR-γ.

Journal: International immunopharmacology

Published: July 27, 2024

The exploration of surgery and survival prediction in patients with peritoneal metastasis from gastric adenocarcinoma based on the SEER database.

Journal: Journal of gastrointestinal oncology

Published: November 02, 2023